Requested OTC NSAID Labeling Includes Cardiac Risk, Front Panel Changes
This article was originally published in The Tan Sheet
Executive Summary
Manufacturers of over-the-counter non-steroidal anti-inflammatory drugs should prominently identify their products as NSAIDs on packaging, according to an FDA request
You may also be interested in...
Decision For McNeil In Children's Motrin Suit Notes Limits Of OTC Labeling
A federal court ruling cautions that drugs should not be expected to have labels that "guarantee against every conceivable adverse consequence.
Decision For McNeil In Children's Motrin Suit Notes Limits Of OTC Labeling
A federal court ruling cautions that drugs should not be expected to have labels that "guarantee against every conceivable adverse consequence.
Decision For McNeil In Children's Motrin Suit Notes Limits Of OTC Labeling
A federal court ruling cautions that drugs should not be expected to have labels that "guarantee against every conceivable adverse consequence.